<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for NKTR</title>
    <link />
    <description>Headlines for Nektar Therapeutics</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Nektar Posts Wider Loss, Maintains View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99452/nektar-posts-wider-loss-maintains-view.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 15 May 2013 11:26:01 GMT</pubDate>
    </item>
    <item>
      <title>Nektar Therapeutics Enters Oversold Territory (NKTR)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920216/1/nektar-therapeutics-enters-oversold-territory-nktr.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 12:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Nektar's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1422771-nektar-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 00:20:03 GMT</pubDate>
    </item>
    <item>
      <title>Bayer Initiates Phase III Trial of BAY41-6551T, Delivered by a Pulmonary Drug Delivery System Develo</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3499414/bayer-initiates-phase-iii-trial-of-bay41-6551t-delivered-by-a-pulmonary-drug-deli.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 16 Apr 2013 05:52:21 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks to Get on Your Watchlist</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/10/3-stocks-to-get-on-your-watchlist-29/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 10 Apr 2013 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Positive Data on Nektar's NKTR-214 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96555/positive-data-on-nektars-nktr-214.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 18:08:01 GMT</pubDate>
    </item>
    <item>
      <title>Here's Why Nektar Therapeutics's Latest Report Might Worry You</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/03/heres-why-nektar-therapeuticss-latest-report-migh/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 03 Apr 2013 13:05:02 GMT</pubDate>
    </item>
    <item>
      <title>Several Big Growth Stories In Biotech: Keith Markey</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1308521-several-big-growth-stories-in-biotech-keith-markey.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Mar 2013 20:13:07 GMT</pubDate>
    </item>
    <item>
      <title>What Is In The Future For Nektar?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1291631-what-is-in-the-future-for-nektar.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 08:06:34 GMT</pubDate>
    </item>
    <item>
      <title>Nektar Loss Widens, Gives Guidance - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94245/nektar-loss-widens-gives-guidance.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 07 Mar 2013 12:41:01 GMT</pubDate>
    </item>
    <item>
      <title>Nektar Therapeutics Beats on the Top Line</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/01/nektar-therapeutics-beats-on-the-top-line/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 01 Mar 2013 14:32:21 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Deutsche Bank Reiterates Buy Rating, Lowers PT on Nektar Therapeutics on Q4 Loss</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3381790/update-deutsche-bank-reiterates-buy-rating-lowers-pt-on-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 11:27:29 GMT</pubDate>
    </item>
    <item>
      <title>Nektar Therapeutics CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1236801-nektar-therapeutics-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Feb 2013 22:55:03 GMT</pubDate>
    </item>
    <item>
      <title>AZN Reports Naloxegol Safety Data  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93644/azn-reports-naloxegol-safety-data.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 27 Feb 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Synergy Targets Root Cause Of Irritable Bowel Syndrome</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1219201-synergy-targets-root-cause-of-irritable-bowel-syndrome.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 24 Feb 2013 06:11:51 GMT</pubDate>
    </item>
    <item>
      <title>4 Stocks Under $10 Spiking Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-stocks-under-10-spiking-higher.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 22 Feb 2013 15:16:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Poised for Breakouts</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-23.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 01 Feb 2013 13:09:00 GMT</pubDate>
    </item>
    <item>
      <title>Nektar Therapeutics' CEO Presents at JP Morgan Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1103031-nektar-therapeutics-ceo-presents-at-jp-morgan-healthcare-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 09 Jan 2013 13:43:03 GMT</pubDate>
    </item>
    <item>
      <title>A House of Pain for Zogenix</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/09/a-house-of-pain-for-zogenix/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 09 Jan 2013 11:13:00 GMT</pubDate>
    </item>
    <item>
      <title>J.P. Morgan Healthcare Confab Live Blog Day Three</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11804391/1/jp-morgan-healthcare-confab-live-blog-day-three.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 09 Jan 2013 10:01:00 GMT</pubDate>
    </item>
  </channel>
</rss>
